drugset / Trial / NCT03137407
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The specific aim of the study is to compare the safety and efficacy of a single administration of DaxibotulinumtoxinA for Injection versus placebo for managing plantar fasciitis.
Timeline
- Start
- 2017-06-12
- Primary completion
- 2018-02-20
- Completion
- 2018-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 240 iu | Intramuscular |